Leaflet MIALGIN 100mg/2ml 50mg / ml solution for injection

Indicated for: moderate to severe pain

Route of administration: injectable

Substance: pethidine (opioid analgesic)

ATC: N02AB02 (Nervous system | Opioids | Phenylpiperidine derivatives)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse
Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression
Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol
Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Pethidine is an opioid analgesic used for the treatment of moderate to severe pain, including during labor or surgical procedures. It works by binding to opioid receptors in the central nervous system, reducing the perception of pain.

The medication is administered orally, intramuscularly, or intravenously, as directed by a doctor. It is important for patients to follow the recommended dosage and avoid long-term use to prevent dependency.

Patients should be aware of potential side effects, such as drowsiness, dizziness, or constipation. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dizziness, and constipation. In rare cases, severe reactions such as respiratory depression or allergic reactions may occur. Patients should be informed of these risks before use.

General data about MIALGIN 100mg/2ml 50mg / ml

  • Substance: pethidine
  • Date of latest medicines list: 01-06-2026
  • Product code: W42905002
  • Concentration: 50mg / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 2 ml
  • Product type: Generic medicine
  • Price: 61.78 RON
  • Prescription status: TAB2 - Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

  • Manufacturer: ZENTIVA SA - ROMANIA
  • Holder: ZENTIVA SA - ROMANIA
  • Number: 11708/2019/01
  • Shelf life: 3 years

Compensation lists for MIALGIN 100mg/2ml 50mg / ml Zentiva

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price

Copayment

Patient

61.78 RON

61.78 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

61.78 RON

61.78 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

61.78 RON

61.78 RON

0.00 RON